DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,464,989 | +3.9% | 26,058 | +0.5% | 0.12% | +6.1% |
| Q2 2023 | $6,224,400 | -4.9% | 25,935 | -0.2% | 0.11% | -13.0% |
| Q1 2023 | $6,546,739 | -7.8% | 25,975 | -2.9% | 0.13% | -12.1% |
| Q4 2022 | $7,101,578 | +3.6% | 26,756 | +0.8% | 0.15% | -3.9% |
| Q3 2022 | $6,857,000 | +4.9% | 26,548 | +2.9% | 0.16% | +12.3% |
| Q2 2022 | $6,537,000 | -13.7% | 25,788 | -0.2% | 0.14% | +3.0% |
| Q1 2022 | $7,578,000 | -10.8% | 25,834 | +0.0% | 0.13% | -2.9% |
| Q4 2021 | $8,499,000 | +2.0% | 25,832 | -5.6% | 0.14% | -8.6% |
| Q3 2021 | $8,333,000 | +10.5% | 27,372 | -2.6% | 0.15% | +9.4% |
| Q2 2021 | $7,542,000 | +18.8% | 28,103 | -0.4% | 0.14% | +9.5% |
| Q1 2021 | $6,351,000 | +0.7% | 28,216 | -0.6% | 0.13% | -7.4% |
| Q4 2020 | $6,306,000 | +3.3% | 28,389 | +0.1% | 0.14% | -8.7% |
| Q3 2020 | $6,107,000 | +20.7% | 28,362 | -0.9% | 0.15% | +10.4% |
| Q2 2020 | $5,059,000 | +31.2% | 28,612 | +2.7% | 0.14% | +6.3% |
| Q1 2020 | $3,856,000 | -9.9% | 27,862 | -0.1% | 0.13% | +10.4% |
| Q4 2019 | $4,280,000 | +4.0% | 27,890 | -2.2% | 0.12% | -5.0% |
| Q3 2019 | $4,117,000 | +0.6% | 28,508 | -0.5% | 0.12% | -2.4% |
| Q2 2019 | $4,093,000 | +7.1% | 28,640 | -1.1% | 0.12% | +0.8% |
| Q1 2019 | $3,823,000 | +28.5% | 28,960 | +0.4% | 0.12% | +9.8% |
| Q4 2018 | $2,974,000 | -6.7% | 28,836 | -1.7% | 0.11% | +9.8% |
| Q3 2018 | $3,189,000 | +3.4% | 29,343 | -6.1% | 0.10% | -2.9% |
| Q2 2018 | $3,084,000 | +2.9% | 31,258 | +2.1% | 0.10% | -7.9% |
| Q1 2018 | $2,997,000 | +1.8% | 30,605 | -3.5% | 0.11% | +3.6% |
| Q4 2017 | $2,945,000 | +7.6% | 31,725 | -0.6% | 0.11% | +2.8% |
| Q3 2017 | $2,737,000 | 0.0% | 31,902 | -1.6% | 0.11% | +0.9% |
| Q2 2017 | $2,737,000 | +2.2% | 32,437 | +3.6% | 0.11% | +1.0% |
| Q1 2017 | $2,677,000 | +5.4% | 31,303 | -4.1% | 0.10% | 0.0% |
| Q4 2016 | $2,541,000 | +6.0% | 32,645 | +6.7% | 0.10% | +6.1% |
| Q3 2016 | $2,398,000 | -22.4% | 30,590 | 0.0% | 0.10% | -27.7% |
| Q2 2016 | $3,090,000 | +3.8% | 30,590 | -2.6% | 0.14% | +3.8% |
| Q1 2016 | $2,978,000 | +0.8% | 31,401 | -1.3% | 0.13% | -3.6% |
| Q4 2015 | $2,954,000 | +10.6% | 31,801 | +1.4% | 0.14% | +7.0% |
| Q3 2015 | $2,671,000 | -0.4% | 31,349 | 0.0% | 0.13% | +5.8% |
| Q2 2015 | $2,683,000 | +8.3% | 31,349 | +7.5% | 0.12% | +6.1% |
| Q1 2015 | $2,477,000 | +5.7% | 29,157 | +6.7% | 0.11% | -2.6% |
| Q4 2014 | $2,343,000 | +15.9% | 27,316 | +2.6% | 0.12% | +15.8% |
| Q3 2014 | $2,022,000 | -1.4% | 26,626 | +2.2% | 0.10% | -4.7% |
| Q2 2014 | $2,050,000 | +8.0% | 26,049 | +2.9% | 0.11% | 0.0% |
| Q1 2014 | $1,898,000 | +2.0% | 25,304 | +5.0% | 0.11% | +3.9% |
| Q4 2013 | $1,861,000 | +10.8% | 24,104 | -0.5% | 0.10% | +6.2% |
| Q3 2013 | $1,679,000 | +10.2% | 24,227 | +0.6% | 0.10% | +11.6% |
| Q2 2013 | $1,524,000 | – | 24,071 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |